Sprint to Fitness: Effect of Outcome Expectations on Responses to Interval Exercise Training
Effect of Outcome Expectations on Psychological and Physiological Responses to Interval Exercise Training
1 other identifier
interventional
66
1 country
1
Brief Summary
The purpose of this study is to research the effects of exercising at high intensities for short periods of time on exercise tolerance and motivation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2017
CompletedFirst Posted
Study publicly available on registry
May 22, 2017
CompletedStudy Start
First participant enrolled
November 29, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 21, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 21, 2019
CompletedApril 11, 2025
April 1, 2025
1.9 years
May 19, 2017
April 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in relative reinforcing value (RRV) of physical activity
RRV of physical activity will be assessed by evaluating the number of responses (mouse button presses) a subject is willing to complete to gain access to physical activity or a sedentary alternative.
Week 0, Week 6, Week 10
Changes in preference for intense physical activity and tolerance for exercise discomfort
Changes in preference for intense physical activity and tolerance for exercise discomfort will be assessed by self-report questionnaire responses to the Preference for and Tolerance of the Intensity of Exercise Questionnaire (PRETIE-Q). The PRETIE-Q measures preference for high intensity vs. low intensity exercise and ability to persist or tolerate the discomfort associationed with intense exercise. The PRETIE-Q consists of two subscales: Preference for Exercise Intensity and Tolerance of Exercise Intensity. Each subscale has 8 items rated on a 5 point response scale (range 8 - 40). Higher scores indicate greater preference for intense exercise and/or greater tolerance for exercise discomfort. Total scale scores are not used. Scale averages will be used.
Week 0, Week 6, Week 10
Secondary Outcomes (15)
Change in minutes of physical activity, as assessed by activity tracker
Week 0, Week 6, Week 10
Changes in quadriceps and hamstring (thigh muscle) strength assessed separately on each leg
Week 0, Week 6, Week 10
Changes in aerobic fitness, as assessed using the Standardized Exponential Exercise Protocol (STEEP)
Week 0, Week 6, Week 10
Changes in anaerobic power, as during a Wingate anaerobic power exercise test
Week 0, Week 6, Week 10
Changes in fat mass as assessed by dual energy x-ray absorptiometry (DXA) scans
Week 0, Week 6, Week 10
- +10 more secondary outcomes
Study Arms (2)
HIIT + POE
EXPERIMENTALHigh-intensity interval training (HIIT) plus positive outcome expectations (POE) from participating in the exercise program.
HIIT only
EXPERIMENTALHigh-intensity interval training (HIIT) only.
Interventions
Subjects will participate in high-intensity interval training (HIIT) with an additional treatment component to increase positive outcome expectations (POE) of exercise.
Eligibility Criteria
You may qualify if:
- Body Mass Index of 25-35 kg/m2
- Sedentary (not regularly engaging in exercise more than once per week)
- Weight stable (have not lost or gained over 10 pounds of body weight in the past 3 months)
You may not qualify if:
- Taking any medications that affect energy expenditure or treat high blood pressure
- Tobacco use
- Pregnant or breastfeeding or plan to become pregnant in the next 3 months
- Have any medical conditions that prevent subject from safely exercising (e.g., orthopedic injuries, cardiovascular, liver, endocrine, or pulmonary diseases)
- Resting systolic blood pressure ≥ 140 mmHg
- Resting diastolic blood pressure ≥ 90 mmHg
- Non-fasting plasma glucose of ≥ 200 mg/dl
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
USDA Grand Forks Human Nutrition Research Center
Grand Forks, North Dakota, 58203, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
James N Roemmich, PhD
USDA Grand Forks Human Nutrition Research Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 19, 2017
First Posted
May 22, 2017
Study Start
November 29, 2017
Primary Completion
October 21, 2019
Study Completion
October 21, 2019
Last Updated
April 11, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share